Access Pharmaceuticals Reports Significant Oral Bioavailability of Cobalamin(TM) Oral Insulin in Additional Studies

Thursday, March 11, 2010 General News
Email Print This Page Comment bookmark
Font : A-A+

Cobalamin Seen As Broadly Applicable For Oral Delivery Of Many Large Molecule Drugs Now Administered By Injection

Contact: Company

Contact: Investor Relations

Stephen B. Thompson

Donald C. Weinberger/Diana Bittner (media)

Vice President, Chief Financial Officer

Wolfe Axelrod Weinberger Assoc. LLC

Access Pharmaceuticals, Inc.

(212) 370-4500

(214) 905-5100

Christine Berni

Director of Investor Relations

Access Pharmaceuticals, Inc.

(212) 786-6208



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook